Skip to main content
MedPathMedPath Home
Clinical Trials/IRCT20230724058907N1
IRCT20230724058907N1
Recruiting
Phase 3

Evaluation of nebulized heparin efficacy in pediatric patients with acute respiratory distress syndrome

Ahvaz University of Medical Sciences0 sites66 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Ahvaz University of Medical Sciences
Enrollment
66
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • •Children older than one month to 18 years old
  • •The underlying disease of acute respiratory distress syndrome
  • •Patients under mechanical ventilation for more than 48 hours with Pao2/Fio2\<300
  • •Patients who are expected to undergo invasive ventilation in the next 24 hours
  • •In CXR, bilateral pulmonary infiltration can be seen (5cmH2O PEEP\>)

Exclusion Criteria

  • •History of allergy to heparin
  • •Bleeding history in the last 3 months
  • •History of any bleeding and coagulation disorders
  • •History of cerebral hemorrhage in the last year
  • •Uncontrolled active bleeding
  • •Simultaneous use of antiplatelet, anticoagulant and thrombolytic drugs
  • •Unwillingness to participate in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Phase 2
The Evaluation of effectiveness of heparin nebulizer in reduction of respiratory distress in patients with COVID-19COVID-19.COVID-19, virus identifiedU07.1
IRCT20210513051275N1Islamic Azad University60
Completed
Phase 3
Evaluation of the effect of nebulized heparin on days without ventilator in intensive care unit patientsAcute respiratory distress syndrom.Other acute and subacute respiratory conditions due to chemicals, gases, fumes and vaporsJ68.3
IRCT20211010052718N2Mazandaran University of Medical Sciences74
Completed
Phase 2
Heparin administration in coronary angiographyAtherosclerotic heart disease.Atherosclerotic heart disease
IRCT201202199080N1Hamadan university of medical sciences500
Completed
Phase 3
Investigation of the effect of inhaled heparin in the treatment of patients with adult respiratory distress syndrome hospitalized in the intensive care unitAcute respiratory distress syndrome.Acute respiratory distress syndrome
IRCT20190506043492N4Ahvaz University of Medical Sciences60
Recruiting
Phase 3
Comparison of inhaled heparin/N-acetylcysteine, N-acetylcystein alone, and placepo for the treatment of COVID-19 patientsCOVID-19.Coronavirus infection, unspecifiedB34.2
IRCT20201210049672N1Vice-Chancellery for Research Hormozgan University of Medical Sciences25